Cat.#: ACPP-1090
| Despition | PAX5 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1748 | Human PAFAH1B3 Protein (AC1748) | 5 µg | inquiry |
| ACPP-1325 | Synaptotagmin 1 Blocking Peptide (AC1325) | 250 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1155 | Recombinant Human PCDH18 Protein (6×His Tag) (AC1155) | 50 µg | inquiry |
| ACPP-1316 | GPCR GPR7 Blocking Peptide (AC1316) | 250 µg | inquiry |
| ACPP-1539 | Human Acrp30 (108-244) Protein (AC1539) | 5 µg | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1378 | Human EFNB3 Protein (AC1378) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.